AVAI — Avai Bio Cashflow Statement
0.000.00%
Last trade - 00:00Annual cashflow statement for Avai Bio, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.127 | -0.349 | -2.13 | -1.14 | -1.75 |
| Depreciation | |||||
| Non-Cash Items | -0.012 | -0.003 | — | — | — |
| Unusual Items | |||||
| Changes in Working Capital | -0.433 | 0.274 | 0.729 | -0.093 | 0.714 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -0.535 | -0.054 | -1.32 | -1.16 | -1.01 |
| Capital Expenditures | — | -0.034 | -0.149 | 0 | — |
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.034 | 0 | — | — | — |
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | 0.034 | -0.034 | -0.149 | 0 | — |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.474 | 0.162 | 1.36 | 1.24 | 0.952 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.027 | 0.074 | -0.107 | 0.081 | -0.058 |